{"h1":"How CDSCO, FDA and EU MDR regulate a developmental-AI tool","faq":[{"a":"No. Classification turns on intended use. A tool that screens and routes a child to a clinician without making a diagnostic claim may sit outside the SaMD boundary or in a low-risk tier; once it informs clinical decisions it falls within CDSCO, FDA and EU MDR oversight.","q":"Is every developmental-AI tool a medical device?"},{"a":"Under the Medical Devices Rules, 2017, clinical software is risk-classified A–D. Screening and assessment-support tools typically fall in Class A or B (low–moderate risk), requiring registration, a quality management system and proportionate clinical evidence. Pinnacle's AbilityScore® is referenced as CDSCO Class B SaMD.","q":"What risk class does CDSCO assign developmental software?"},{"a":"Standalone medical software is classified chiefly under Rule 11, which generally places diagnostic or decision-driving software in Class IIa or higher, requiring a Notified Body conformity assessment, clinical evaluation and post-market surveillance.","q":"How does the EU MDR classify clinical software?"},{"a":"The FDA applies risk-based oversight and uses a Predetermined Change Control Plan framework, allowing pre-authorised modifications to learning AI/ML software while preserving safety and performance assurance.","q":"How does the FDA handle AI tools that update over time?"}],"lang":"en","slug":"how-is-a-developmental-ai-tool-regulated-by-cdsco-fda-and-eu-mdr","title":"How is a developmental-AI tool regulated by CDSCO, FDA and EU MDR?","entity":{"key":"reg_samd","kind":"field_vantage","name":"Regulatory & Compliance","slug":null},"lenses":[{"kind":"stakeholder","label":"Professional","value":"professional"},{"kind":"intent","label":"Support","value":"support"},{"kind":"lifecycle","label":"Plan","value":"plan"},{"kind":"route","label":"About","value":"about"}],"parent":null,"related":[{"lang":"en","slug":"what-is-software-as-a-medical-device-samd-in-child-health","title":"What is Software as a Medical Device (SaMD) in child health?"},{"lang":"en","slug":"what-is-the-clinical-and-regulatory-basis-of-therapeuticai","title":"What is the clinical and regulatory basis of TherapeuticAI®?"},{"lang":"en","slug":"what-data-privacy-rules-apply-to-children-s-health-data-in-india","title":"What data-privacy rules apply to children's health data in India?"},{"lang":"en","slug":"how-is-ai-used-in-child-developmental-assessment","title":"How is AI used in child developmental assessment?"},{"lang":"en","slug":"how-do-you-build-software-for-tracking-child-development","title":"How do you build software for tracking child development?"},{"lang":"en","slug":"what-is-the-clinical-and-regulatory-basis-of-abilityscore","title":"What is the clinical and regulatory basis of AbilityScore®?"}],"summary":"A developmental-AI tool is regulated by intended use and risk class: CDSCO treats clinical SaMD under the Medical Device Rules 2017 (Class A–D), the FDA applies risk-based SaMD oversight under the FD&C Act, and the EU MDR classifies software chiefly via Rule 11. Tools that screen and route without diagnosing may sit at a lower risk tier. AbilityScore® is part of Pinnacle’s developmental assessment. Diagnosis, where needed, requires an appropriately qualified healthcare professional.","answer_md":"*A developmental-AI tool earns the right to support a child's care by clearing the same regulatory bars as any medical software — and by being honest about where its claims begin and end.*\n\n## In short\nA developmental-AI tool is regulated according to its **intended use and risk class**. In India, the **CDSCO** treats clinically-purposed Software as a Medical Device (SaMD) under the Medical Device Rules, 2017; in the United States, the **FDA** evaluates it as SaMD under the FD&C Act and its digital-health framework; in the European Union, the **EU MDR (2017/745)** classifies it via Rule 11 for software. A tool that only supports or screens — without making a diagnostic claim — may sit *outside* the SaMD boundary, but the moment it informs clinical decisions it falls squarely within these regimes.\n\n## How each regime treats developmental AI\n- **CDSCO (India)** — Under the Medical Devices Rules, 2017, software with a medical purpose is risk-classified A–D. A developmental screening or assessment-support tool typically lands in **Class A or B (low–moderate risk)**, requiring registration, a quality management system, and clinical evidence proportionate to its claims. Pinnacle's AbilityScore® is referenced as **CDSCO Class B SaMD**.\n- **FDA (United States)** — The FDA assesses whether software meets the device definition, then applies risk-based oversight (510(k), De Novo, or enforcement discretion for lower-risk wellness or clinical-decision-support tools). Its **Predetermined Change Control Plan** framework is central for AI/ML tools that learn or update over time.\n- **EU MDR (European Union)** — Standalone medical software is classified chiefly under **Rule 11**, which tends to push diagnostic and decision-driving software into **Class IIa or higher**, demanding a Notified Body conformity assessment, clinical evaluation, and post-market surveillance.\n\nAcross all three, the determining question is the **claim**: a tool that *screens, monitors and routes* a child to a clinician carries lighter obligations than one that *diagnoses*. Transparency about training data, performance, bias mitigation and human oversight is now expected everywhere.\n\n## Where a support tool sits\nMany developmental-AI tools are deliberately scoped as **screening and triage aids that never replace clinical judgement** — they flag what merits a closer look and route families to qualified clinicians. This keeps them in a lower-risk tier while preserving child safety, because the diagnostic decision always rests with a human professional in a regulated setting.\n\n## The Pinnacle way\nAbilityScore® is part of Pinnacle’s developmental assessment. Diagnosis, where needed, requires an appropriately qualified healthcare professional — never from an algorithm alone. The AbilityScore® is a clinician-administered structured assessment, registered as **CDSCO Class B SaMD**, built on 2.5 billion+ data points and 25 million+ therapy sessions, and protected by 16+ WIPO PCT patents with 12 validated studies behind it. Explore the [Pinnacle network](/), understand [what the AbilityScore® is and how it is administered](/ask/what-is-the-abilityscore-and-how-is-it-calculated), and see how it connects to [speech therapy](https://www.pinnacleblooms.org/top-speech-therapy-center-india-proven-improvement-rate) and family-facing care.\n\n## Trusted sources\nWHO guidance on the classification of digital health interventions; CDSCO Medical Devices Rules framework for Software as a Medical Device; US FDA digital-health and SaMD oversight resources; EU MDR (Regulation 2017/745) software classification under Rule 11.\n\n**Next step —** Evaluating a developmental-AI tool for clinical or institutional use? [Contact the Pinnacle regulatory and clinical team](/) to discuss SaMD scope, evidence and safe deployment.\n\nThis is general information, not a diagnosis — individual assessment and diagnosis require an appropriately qualified healthcare professional.","canonical":"https://pinnacleblooms.org/ask/how-is-a-developmental-ai-tool-regulated-by-cdsco-fda-and-eu-mdr","editorial":{"reviewed_at":"2026-06-11T20:12:18.613642+00:00","reviewed_by":null,"developed_by":"SETU Consortium · Pinnacle Blooms Network"},"alternates":[{"href":"https://pinnacleblooms.org/ask/how-is-a-developmental-ai-tool-regulated-by-cdsco-fda-and-eu-mdr","lang":"en","indexable":true}],"dimensions":[],"meta_title":"Developmental AI: CDSCO, FDA & EU MDR Rules","meta_robots":"index, follow, max-image-preview:large","everyday_tip":"When assessing any developmental-AI tool, ask first what it claims to do — the claim, not the technology, sets the regulatory class and the evidence it must show.","published_at":"2026-06-10T14:16:00.221239+00:00","reading_paths":[{"key":"understand","items":[{"lang":"en","slug":"what-is-the-clinical-and-regulatory-basis-of-abilityscore","title":"What is the clinical and regulatory basis of AbilityScore®?","reason":"Linked from this answer"},{"lang":"en","slug":"what-is-the-clinical-and-regulatory-basis-of-therapeuticai","title":"What is the clinical and regulatory basis of TherapeuticAI®?","reason":"Linked from this answer"}],"label":"Understand the subject","total":2},{"key":"therapy","items":[{"lang":"en","slug":"what-is-software-as-a-medical-device-samd-in-child-health","title":"What is Software as a Medical Device (SaMD) in child health?","reason":"Linked from this answer"},{"lang":"en","slug":"how-do-you-build-software-for-tracking-child-development","title":"How do you build software for tracking child development?","reason":"Linked from this answer"},{"lang":"en","slug":"how-is-ai-used-in-child-developmental-assessment","title":"How is AI used in child developmental assessment?","reason":"Linked from this answer"},{"lang":"en","slug":"what-data-privacy-rules-apply-to-children-s-health-data-in-india","title":"What data-privacy rules apply to children's health data in India?","reason":"Linked from this answer"}],"label":"Explore therapy & support","total":4}],"what_to_watch":"Watch the tool's stated intended use and claims: a screening or triage aid carries lighter obligations than software making a diagnostic claim, which falls squarely within CDSCO, FDA and EU MDR oversight.","authority_links":[{"url":"https://www.who.int","label":"WHO — classification of digital health interventions"},{"url":"https://www.nice.org.uk","label":"NICE — evidence standards for digital health technologies"}],"last_reviewed_at":"2026-06-10T14:16:00.221239+00:00","meta_description":"How a developmental-AI tool is regulated as Software as a Medical Device under CDSCO (India), FDA (US) and EU MDR — risk class, claims and safe deployment.","related_materials":[],"related_techniques":[]}